May 11, 2020 -- Bio-Techne has released a new kit for cell and gene therapy manufacturing called GMP Cloudz Human T Cell Activation.
The kit is the first in the company's Cloudz product line. It contains Cloudz particles, which are dissolvable microspheres designed for CD3 and CD28 antibodies for the expansion of T cells, the company said. The kit works within the company's T cell culture platform. The particles can be added to CD3+ T cells or peripheral blood mononuclear cells (PBMC), according to Bio-Techne.